These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2613346)

  • 1. High-incidence of C9 deficiency throughout Japan: there are no significant differences in incidence among eight areas of Japan.
    Hayama K; Sugai N; Tanaka S; Lee S; Kikuchi H; Ito J; Suzuki J; Nagata Y; Kondo H; Harayama O
    Int Arch Allergy Appl Immunol; 1989; 90(4):400-4. PubMed ID: 2613346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan.
    Fukumori Y; Yoshimura K; Ohnoki S; Yamaguchi H; Akagaki Y; Inai S
    Int Immunol; 1989; 1(1):85-9. PubMed ID: 2487678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of complement C9 deficiency in Koreans.
    Kang HJ; Kim HS; Lee YK; Cho HC
    Ann Clin Lab Sci; 2005; 35(2):144-8. PubMed ID: 15943177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of the ninth component of complement in man.
    Inai S; Kitamura H; Hiramatsu S; Nagaki K
    J Clin Lab Immunol; 1979 Apr; 2(1):85-7. PubMed ID: 95812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited deficiency of the ninth component of complement associated with streptococcal infection.
    Fujita M; Fujita T; Inai S
    Acta Paediatr Jpn; 1992 Apr; 34(2):169-72. PubMed ID: 1621522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited deficiencies of the late-acting complement components other than C9 found among healthy blood donors.
    Inai S; Akagaki Y; Moriyama T; Fukumori Y; Yoshimura K; Ohnoki S; Yamaguchi H
    Int Arch Allergy Appl Immunol; 1989; 90(3):274-9. PubMed ID: 2592116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of the 9th component of complement (C9) in a patient with systemic lupus erythematosus.
    Kawai T; Katoh K; Narita M; Tani K; Okubo T
    J Rheumatol; 1989 Apr; 16(4):542-3. PubMed ID: 2746595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ELISA for the evaluation of the classical pathway of complement.
    Zwirner J; Wittig A; Kremmer E; Götze O
    J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan.
    Kira R; Ihara K; Watanabe K; Kanemitsu S; Ahmed SU; Gondo K; Takeshita K; Hara T
    J Hum Genet; 1999; 44(2):109-11. PubMed ID: 10083734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of C9 in complement-mediated killing of Neisseria.
    Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG
    J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsense mutation in exon 4 of human complement C9 gene is the major cause of Japanese complement C9 deficiency.
    Kira R; Ihara K; Takada H; Gondo K; Hara T
    Hum Genet; 1998 Jun; 102(6):605-10. PubMed ID: 9703418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The association between deficiency of terminal complement components and the occurrence of meningococcal meningitis].
    Nishizaki M
    Fukuoka Igaku Zasshi; 1992 May; 83(5):201-8. PubMed ID: 1612549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe.
    Zoppi M; Weiss M; Nydegger UE; Hess T; Späth PJ
    Arch Intern Med; 1990 Nov; 150(11):2395-9. PubMed ID: 2241452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence of precipitating antibodies in transfused Japanese patients with hereditary ninth component of complement deficiency and frequency of C9 deficiency.
    Inaba S; Okochi K; Fukada K; Kinoshita S; Maeda Y; Yoshinari M
    Transfusion; 1987; 27(6):475-7. PubMed ID: 3686657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on C9 deficiency.
    Kitamura H; Nagaki K; Inai S
    J Clin Lab Immunol; 1981 Jul; 6(1):7-11. PubMed ID: 7265179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.
    Miura T; Goto S; Iguchi S; Shimada H; Ueno M; Nishi S; Narita I
    Clin Exp Nephrol; 2011 Feb; 15(1):86-91. PubMed ID: 21057849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA nephropathy in patients with congenital C9 deficiency.
    Yoshioka K; Takemura T; Akano N; Okada M; Yagi K; Maki S; Inai S; Akita H; Koitabashi Y; Takekoshi Y
    Kidney Int; 1992 Nov; 42(5):1253-8. PubMed ID: 1453611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited deficiency of the ninth component of complement in man.
    Lint TF; Zeitz HJ; Gewurz H
    J Immunol; 1980 Nov; 125(5):2252-7. PubMed ID: 7430628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biotin-avidin sandwich ELISA for quantification of intact complement component C9. The sera from hereditary C9 deficient individuals completely lack C9.
    Takata Y; Moriyama T; Fukumori Y; Yoden A; Shima M; Inai S
    J Immunol Methods; 1989 Feb; 117(1):107-13. PubMed ID: 2913155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.
    Harriman GR; Podack ER; Braude AI; Corbeil LC; Esser AF; Curd JG
    J Exp Med; 1982 Oct; 156(4):1235-49. PubMed ID: 6818318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.